8 December 2021

Johan van der Vlag, theme Renal disorders, (department of Nephrology) is appointed as chair of the Scientific Advisory Board of the Biotech startup Mercurna.

He will strengthen the development path of mCura1, Mercurna's lead formulation for chronic kidney disease, and will advise about future R&D activities. Together with Mercurna, he will further shape the Scientific Advisory Board as well.

Related news items


Human pluripotent stem cell-derived kidney organoids for personalized congenital and idiopathic nephrotic syndrome modeling

11 May 2022

Bart Smeets, Jitske Jansen and collegues, theme Renal disorders published this article in the Human Development.

read more

ERC Starting Grant awarded to Jeroen de Baaij

17 March 2022

Jeroen de Baaij, kidney researcher the Radboudumc, receives an ERC Starting Grant worth 1.5 million euros. He will use this grant to improve the diagnosis and treatment of severe magnesium deficiencies, which can lead to epileptic seizures and muscle cramps.

read more

Research on the development of kidneys in prematurely born children

17 February 2022

Michiel Schreuder, together with Maastricht UMC+, is now starting a study into the kidneys of these children. For this, the researchers received a grant from the Kidney Foundation. 

read more

Laurens Verscheijden awarded doctorate degree 'cum laude'

19 January 2022

Laurens Verscheijden of the Department of Pharmacology and Toxicology, defended his PhD thesis, entitled "Mechanistic models for the prediction of brain drug exposure and response in the paediatric population: A virtual child reaching maturation.

read more

Academic collaboration agreement between UTwente and Radboudumc

23 November 2021

The group of Biomaterials Science and Technology (BST) of the Faculty of Science and Technology at the TechMed centre of University of Twente has signed a formal academic collaboration agreement with the departments of Nephrology and Physiology at Radboudumc.

read more